Background Cellular transplantations have promising effects on treating spinal cord injury
(SCI) patients. Mesenchymal stem cells (MSCs) and Schwann cells (SCs), which have safety …

Background aims Cell replacement therapy has become a promising issue that has raised
much hope in the regeneration of central nervous system injury. Evidence indicates that …

Due to lack of well-designed trials, there is no good evidence on the efficacy of stem cells in
spinal cord injury. We aim to study the efficacy and outcome of bone marrow derived stem …

Spinal cord injury (SCI) is a severe neurological disease. An effective strategy for the
treatment of SCI is urgently required. Stem cell transplantation has emerged as a viable …

BACKGROUND: In recent years, some studies were conducted to evaluate the effects of
stem cells from different sources on patients with spinal cord injury (SCI). This study was …

Introduction The administration of stem cells holds promise as a potential therapy for spinal
cord injury (SCI). Mesenchymal stem cells have advantages for clinical applications, since …

Stem cell transplantation has been applied to treat spinal cord injury (SCI) in clinical trials for
many years. However, the clinical efficacies of stem cell transplantation in SCI have been …

With technological advances in basic research, the intricate mechanism of secondary
delayed spinal cord injury (SCI) continues to unravel at a rapid pace. However, despite our …

Spinal cord injury (SCI) is a severe traumatic disease of the central nervous system, with a
global prevalence of 236–4187 per million people. This meta-analysis aimed to evaluate the …

Background aims Mesenchymal stromal cell (MSC) transplantation has immerged as
promising therapeutic approach to treat spinal cord injury (SCI). In this pilot study, we …